Improving heart failure care with reduced pumping ability
Part of Heart & circulation clinical trials.
This study evaluates how well doctors follow guidelines for treating heart failure with reduced ejection fraction (HFrEF). It aims to improve the quality of care you receive during your regular clinic visits over the next year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a diagnosis of heart failure with reduced ejection fraction (HFrEF) — meaning your heart's pumping ability is below 50%.
- You must be willing to participate in follow-up at the study clinic for 1 year.
- Your doctor must expect you to live at least 1 more year.
- You must not have had a major heart event or open-heart surgery in the past 3 months that could interfere with treatment.
- You must not be planned for a heart pump (LVAD) or heart transplant within the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well patients with heart failure and a weakened heart muscle (ejection fraction of 40% or lower) do when taking the recommended heart failure medications. The goal is to see if these treatments improve their heart function and quality of life.
This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.
This trial tests whether safely increasing the dose of standard heart failure medications can improve outcomes in people with a weak heart pump, while keeping a close eye on kidney function. It may be a good fit if you have heart failure with reduced ejection fraction and are not yet on the highest recommended doses of your medicines.
This study looks at how well patients with heart failure who have reduced pumping function do when they receive the standard recommended medications. It aims to see short-term improvements in heart function and symptoms.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
This trial tests an investigational medicine called CRD-4730 (taken as a pill) to see if it can improve heart function and symptoms in people with heart failure and a reduced pumping ability. It may help you feel better and slow the progression of your condition.
Hear when a new Guideline Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.